Study of a Neuroprotective Drug to Limit the Extent of Damage From an Ischemic Stroke

NCT00630396 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

David Hess, MD

Collaborators